Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Working Capital Changes (2016 - 2026)

Champions Oncology has reported Other Working Capital Changes over the past 17 years, most recently at -$2.3 million for Q1 2026.

  • Quarterly results put Other Working Capital Changes at -$2.3 million for Q1 2026, down 553.63% from a year ago — trailing twelve months through Jan 2026 was -$1.1 million (up 59.37% YoY), and the annual figure for FY2025 was $3.3 million, up 386.48%.
  • Other Working Capital Changes for Q1 2026 was -$2.3 million at Champions Oncology, down from -$2.1 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CSBR hit a ceiling of $5.2 million in Q2 2022 and a floor of -$2.3 million in Q1 2026.
  • Median Other Working Capital Changes over the past 5 years was -$325000.0 (2023), compared with a mean of $167647.1.
  • Peak annual rise in Other Working Capital Changes hit 1597.7% in 2022, while the deepest fall reached 5835.71% in 2022.
  • Champions Oncology's Other Working Capital Changes stood at $300000.0 in 2022, then crashed by 208.33% to -$325000.0 in 2023, then decreased by 21.23% to -$394000.0 in 2024, then tumbled by 430.71% to -$2.1 million in 2025, then decreased by 11.91% to -$2.3 million in 2026.
  • The last three reported values for Other Working Capital Changes were -$2.3 million (Q1 2026), -$2.1 million (Q4 2025), and -$1.0 million (Q3 2025) per Business Quant data.